QQ客服 官方微博 反馈留言

浏览/检索结果: 共10条，第1-10条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 MiR-92b targets p57kip2 to modulate the resistance of hepatocellular carcinoma (HCC) to ionizing radiation (IR)-based radiotherapy 期刊论文 2019, 卷号: 110, 页码: 646-655 作者:  Wang, Jianyang;  Zhao, Hong;  Yu, Jing;  Xu, Xin;  Liu, Wenyang 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 Hepatocellular carcinoma (HCC)  miR-92b  p57kip2  Radioresistance  Ionizing radiation   PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma 期刊论文 2018, 卷号: 37 作者:  Zhou, Wuhua;  Gong, Li;  Wu, Qinchuan;  Xing, Chunyang;  Wei, Bajin 收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03 Plant homeodomain finger protein 8  PHF8  Epithelial-mesenchymal transition  EMT  Autophagy  Metastasis  Hepatocellular carcinoma  HCC   Prognostic role of neutrophil-to-lymphocyte ratio in unresectable hepatocellular cancer patients treated with trans-arterial chemoembolization 期刊论文 2018, 卷号: 7, 期号: 4, 页码: 1122-1134 作者:  Xu, Weiyu;  Xiong, Jianping;  Lin, Jianzhen;  Long, Junyu;  Bai, Yi 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Neutrophil-to-lymphocyte (NLR)  trans-arterial chemoembolization (TACE)  hepatocellular carcinoma (HCC)  prognosis   The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction 期刊论文 2018, 卷号: 14, 期号: 13, 页码: 1845-1858 作者:  He, Bin;  Dai, Longfei;  Zhang, Xiaoqian;  Chen, Diyu;  Wu, Jingbang 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03 Histone deacetylases (HDACs)  Histone deacetylases inhibitors (HDACis)  Hepatocellular Carcinoma cells (HCC cells)  quisinostat (JNJ-26481585)  sorafenib  synergistic effect   Research progress on DNA methylation in hepatocellular carcinoma 期刊论文 2017, 卷号: 6, 期号: 5, 页码: 981-998 作者:  Zheng, Yongchang;  Wang, Xin;  Xie, Feihu;  Gu, Zhaoqi;  He, Li 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Hepatocellular carcinoma (HCC)  methylation  gene chip analysis  whole genome sequencing  early diagnosis   PSG9 promotes angiogenesis by stimulating VEGFA production and is associated with poor prognosis in hepatocellular carcinoma 期刊论文 2017, 卷号: 60, 期号: 5,SI, 页码: 528-535 作者:  Rong Weiqi;  Yang Lei;  Yin Liyuan;  Gao Yanning;  Xiao Ting 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 hepatocellular carcinoma (HCC)  PSG9  VEGFA  angiogenesis   Serum cytokeratin-18 is a non-invasive biomarker for evaluating disease severity in patients with liver cirrhosis and hepatocellular carcinoma 期刊论文 2017, 卷号: 6, 期号: 6, 页码: 1345-1350 作者:  Yang, Huayu;  Sun, Lejia;  Sheng, Langqing;  Wang, Xiaowei;  Xu, Haifeng 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/04 Cytokeratin-18 (CK18)  cytokeratin-18 fragments  hepatocellular carcinoma (HCC)  cirrhosis  biomarker   Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis 期刊论文 2015, 卷号: 448, 页码: 161-169 作者:  Sun, Da-wei;  Zhang, Ying-yi;  Sun, Xiao-dong;  Chen, Yu-guo;  Qiu, Wei 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13 Cytokeratin 19 (CK-19)  Hepatocellular carcinoma (HCC)  Prognosis  Meta-analysis   Identification of recurrence-related serum microRNAs in hepatocellular carcinoma following hepatectomy 期刊论文 2015, 卷号: 16, 期号: 10, 页码: 1445-1452 作者:  Wang, Liming;  Liu, Mei;  Zhu, Hongxia;  Rong, Weiqi;  Wu, Fan 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/13 hepatocellular carcinoma (HCC)  microRNA (miRNA)  miR-486-5p  recurrence  RFS   Secretory/releasing proteome-based identification of plasma biomarkers in HBV-associated hepatocellular carcinoma 期刊论文 2013, 卷号: 56, 期号: 7, 页码: 638-646 作者:  Yang Lei;  Rong WeiQi;  Xiao Ting;  Zhang Ying;  Xu Bin 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 hepatocellular carcinoma (HCC)  secretome  biomarker  MMP1  OPN  PSG9